Valerio Therapeutics Société anonyme (EPA:ALVIO)
France · Delayed Price · Currency is EUR 0.8500
+0.0800 (10.39%)
Aug 21, 2026, 5:35 PM CET
EPA:ALVIO Market Cap
EPA:ALVIO has a market cap or net worth of €424.53 million as of August 21, 2026. Its market cap has increased by 3,453.00% in one year.
Market Cap
424.53M
Enterprise Value
431.79M
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.85
ChartMarket Cap Chart
Since December 8, 2005, EPA:ALVIO's market cap has increased from 72.77M to 424.53M, an increase of 483.40%. That is a compound annual growth rate of 8.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 424.53M | 529.30% |
| Dec 31, 2025 | 67.46M | 484.18% |
| Dec 31, 2024 | 11.55M | -54.58% |
| Dec 29, 2023 | 25.42M | 62.58% |
| Dec 30, 2022 | 15.64M | -59.41% |
| Dec 31, 2021 | 38.52M | -25.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.93B |
| Inventiva | 949.85M |
| MedinCell | 893.48M |
| DBV Technologies | 739.20M |
| Genfit | 721.35M |
| Valneva SE | 562.49M |
| Transgene | 221.30M |
| Cellectis | 208.64M |